Supporting this hypothesis, a pilot study of ten patients with GBM has revealed a strong correlation between YKL-40 expression on PC/SMCs and tumor vascular stability, permeability and decreased patient survival [60]. The gene discussed is CHI3L1; the disease is glioblastoma.